Surgery Partners (SGRY) closed at $26.95 on November 13, 2026, up 1.4% from the previous close, on volume of 2,671,529 shares (30-day average 5,317,664).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 13, 2026 | Call Spread | 18-Dec-2627.5 : 30 C | 6,106 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Catalyst Watch: Anthropic IPO, Nvidia shockwaves, Nike event, and GTA 6 arrives
Seeking Alpha News (Fri, 13-Nov 3:08 PM ET)
Are SGRY, ADT, CART Obtaining Fair Deals for their Shareholders?
PRNewswire (Wed, 11-Nov 1:43 PM ET)
Globe Newswire (Wed, 11-Nov 6:03 AM ET)
Surgery Partners Faces Escalating Merger Costs and $149 Million Termination Fee Risk
TipRanks (Wed, 11-Nov 1:01 AM ET)
Globe Newswire (Tue, 10-Nov 12:45 PM ET)
Business Wire (Tue, 10-Nov 8:30 AM ET)
RBC Capital Sticks to Their Hold Rating for Surgery Partners (SGRY)
TipRanks (Tue, 10-Nov 6:56 AM ET)
Surgery Partners Non-GAAP EPS of $0.16 beats by $0.04, revenue of $815.3M in-line
Seeking Alpha News (Mon, 9-Nov 5:17 PM ET)
Surgery Partners, Inc. Announces Third Quarter 2026 Results
Globe Newswire (Mon, 9-Nov 4:10 PM ET)
Surgery Partners boosts HealthSpan buyout offer to $25 per share (update)
Seeking Alpha News (Mon, 9-Nov 11:07 AM ET)
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Surgery Partners trades on the NASDAQ stock market under the symbol SGRY.
As of November 13, 2026, SGRY stock price climbed to $26.95 with 2,671,529 million shares trading.
SGRY has a beta of 1.41, meaning it tends to be more sensitive to market movements. SGRY has a correlation of 0.06 to the broad based SPY ETF.
SGRY has a market cap of $3.53 billion. This is considered a Mid Cap stock.
Last quarter Surgery Partners reported $815 million in Revenue and $.16 earnings per share. This fell short of revenue expectation by $-46,976 and exceeded earnings estimates by $.09.
In the last 3 years, SGRY traded as high as $36.92 and as low as $11.41.
The top ETF exchange traded funds that SGRY belongs to (by Net Assets): DFSV, IWM, VTI, DFAT, VB.
SGRY has outperformed the market in the last year with a price return of +76.0% while the SPY ETF gained +13.4%. SGRY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +77.4% and +16.1%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
SGRY support price is $25.90 and resistance is $27.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGRY shares will trade within this expected range on the day.
